Viewing Study NCT02745769


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-02-11 @ 5:50 PM
Study NCT ID: NCT02745769
Status: COMPLETED
Last Update Posted: 2019-03-05
First Post: 2016-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Colorectal Cancer View
None Mantle Cell Lymphoma View
Keywords: